Stocks and Investing Stocks and Investing
Mon, November 2, 2020
Sun, November 1, 2020
Fri, October 30, 2020

A.J. Rice Maintained (AMED) at Buy with Increased Target to $280 on, Oct 30th, 2020


Published on 2024-10-27 14:35:15 - WOPRAI, A.J. Rice
  Print publication without navigation


A.J. Rice of Credit Suisse, Maintained "Amedisys, Inc." (AMED) at Buy with Increased Target from $246 to $280 on, Oct 30th, 2020.

A.J. has made no other calls on AMED in the last 4 months.



There are 6 other peers that have a rating on AMED. Out of the 6 peers that are also analyzing AMED, 1 agrees with A.J.'s Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matt Borsch of "BMO Capital" Maintained at Hold with Increased Target to $270 on, Wednesday, September 2nd, 2020


These are the ratings of the 5 analyists that currently disagree with A.J.


  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Increased Target to $260 on, Monday, September 21st, 2020
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Increased Target to $250 on, Thursday, July 30th, 2020
  • Frank Morgan of "RBC Capital" Maintained at Buy with Increased Target to $260 on, Thursday, July 30th, 2020
  • John Ransom of "Raymond James" Maintained at Buy with Increased Target to $255 on, Thursday, July 30th, 2020
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $260 on, Thursday, July 30th, 2020
Contributing Sources